IGF2 has been reported to improve neurocognitive functioning in patients with autism spectrum disorder,234 Huntington's Disease,138 amyotrophic lateral sclerosis (ALS),235 and Angelman Syndrome.167. This evidence concerns the gene IGF2 and juvenile Huntington disease.